Cellectar Biosciences Accounts Payable

Cellectar Biosciences (CLRB) currently reports a accounts payable of $4.7M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Cellectar Biosciences's accounts payable history and peer comparisons.

Cellectar Biosciences's accounts payable changed from $0 to $4.7M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cellectar Biosciences reported $4.7M in accounts payable as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $4.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cellectar Biosciences, and consider following CLRB for alerts when major investors trade the stock.

Cellectar Biosciences is classified in the Healthcare sector. On accounts payable, it currently shows $4.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLRB with unrelated industries.